06:11 , Aug 10, 2018 |  BC Week In Review  |  Company News

Emergent acquiring vaccine company PaxVax

Biodefense company Emergent BioSolutions Inc. (NYSE:EBS) will acquire vaccine company PaxVax Inc. (Redwood City, Calif.) for $270 million in cash. Emergent will gain Vivotif and Vaxchora, which PaxVax markets to prevent typhoid fever and cholera,...
19:12 , Aug 9, 2018 |  BC Extra  |  Company News

Emergent acquiring vaccine company PaxVax

Biodefense company Emergent BioSolutions Inc. (NYSE:EBS) will acquire vaccine company PaxVax Inc. (Redwood City, Calif.) for $270 million in cash. Emergent will gain Vivotif and Vaxchora, which PaxVax markets to prevent typhoid fever and cholera,...
19:42 , Jul 16, 2018 |  BC Extra  |  Company News

Spero nabs funding for antibiotic

Spero Therapeutics Inc. (NASDAQ:SPRO) said it will receive up to $54.2 million from the Biomedical Advanced Research and Development Authority (BARDA) and Defense Threat Reduction Agency (DTRA) to develop SPR994. From BARDA, the company will...
22:47 , Jun 19, 2018 |  BC Extra  |  Politics & Policy

National Academies recommends defense strategies against biosynthetic weapons

While synthetic biology could be weaponized, similar technology could be used to mitigate those potential threats, concludes a report released Tuesday by the National Academies of Sciences, Engineering, and Medicine (NASEM). In the report, NASEM...
23:41 , Apr 26, 2018 |  BC Extra  |  Politics & Policy

Report: rebates topped $89 billion in 2016

A study by the Altarum Center for Value in Health Care reports that drug manufacturers passed $89 billion in rebates for brand name drugs in 2016 to U.S. health plans and insurers, reducing total retail...
18:41 , Mar 16, 2018 |  BC Week In Review  |  Company News

SEC charges Theranos with fraud

The SEC charged blood-based diagnostic company Theranos Inc. (Palo Alto, Calif.), its founding CEO Elizabeth Holmes and former President Ramesh Balwani with fraudulently raising more than $700 million by exaggerating or making false statements to...
21:25 , Mar 14, 2018 |  BC Extra  |  Company News

SEC charges Theranos with fraud

The SEC charged blood-based diagnostic company Theranos Inc. (Palo Alto, Calif.), its founding CEO Elizabeth Holmes and former President Ramesh Balwani with fraudulently raising more than $700 million by exaggerating or making false statements to...
22:25 , Jan 5, 2018 |  BC Week In Review  |  Clinical News

OncBioMune reports additional Phase I data for prostate cancer vaccine

OncBioMune Pharmaceuticals Inc. (OTCQB:OBMP) reported additional data from 14 evaluable patients with hormone-naïve and hormone-independent recurrent prostate cancer with increasing prostate-specific antigen (PSA; KLK3) levels in a Phase I trial showing that six intradermal injections...
00:33 , Oct 13, 2017 |  BC Week In Review  |  Clinical News

MeMed test distinguishes between bacterial and viral infections

Data published in...
19:55 , Oct 12, 2017 |  BC Innovations  |  Finance

IRDiRC dreams bigger

After presiding over rapid growth in the global effort to diagnose and treat rare diseases over the past six years, the International Rare Diseases Research Consortium (IRDiRC) announced three new goals, one of which is...